Tremfya 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,135
Award facts
- Contract value 100% obligated
- $16,134.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,134.83, awards AmerisourceBergen Drug Corp the supply of TREMFYA (guselkumab) 100 mg/mL syringes to support federal healthcare needs. The contract was awarded on December 30, 2025, as a non-set-aside, competitively awarded delivery order under firm fixed pricing with an ultimate completion date of December 31, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs.
The Defense Logistics Agency, a defense agency within the Department of Defense, funds this procurement as part of its medical supply chain operations serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with DLA for diverse therapeutic products ranging from specialty medications to vaccines and medical devices. The delivery of TREMFYA, a prescription biologic used to treat plaque psoriasis and other inflammatory conditions, supports the pharmaceutical needs of military beneficiaries and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FNQ8L?
SPE2DR26FNQ8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FNQ8L worth?
The government has obligated $16,135 on SPE2DR26FNQ8L.
Is contract SPE2DR26FNQ8L an order under another contract?
Yes. SPE2DR26FNQ8L is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ8L competed?
The extent of competition for SPE2DR26FNQ8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award